COVID-19: Vaccines and Therapeutics
The American Hospital Association urged the Centers for Medicare & Medicaid Services to apply its recently increased Medicare payment rates for COVID-19 vaccine administration services retroactively.
The AHA urged the Centers for Medicare & Medicaid Services to apply its recently increased Medicare payment rates for COVID-19 vaccine administration services retroactively.
The Health Resources and Services Administration will pay health care providers who administer authorized COVID-19 vaccines to patients in health plans that do not cover vaccine administration or cover it with patient cost-sharing, the Department of Health and Human Services announced.
The Centers for Medicare & Medicaid Services Office of Minority Health will host a May 13 webinar on building COVID-19 vaccine confidence.
h4 {text-transform: uppercase;} img {border: 1px solid #efefef;"}
AHA has developed a series of podcasts and resources that explore the different ways hospitals, health systems, and community organizations have worked to improve the equitable distribution and access to the COVID-19 vaccine. We…
Though the COVID-19 pandemic has been a fast-evolving situation, the team at UT Southwestern Medical Center, based in Dallas, has been sharing important and useful information with its communities every step of the way. Now it’s focused on vaccination — offering “what to know” about COVID-19…
As New York City continues to expand vaccine eligibility, NYC Health + Hospitals has been a leader in the race to vaccinate New Yorkers.
On December 16, 2020, occupational therapist Kelly Casey got a history-making shot in her left arm as the first Johns Hopkins staff to be vaccinated.
Just over a year ago, the AHA joined hospital and health system leaders at the White House to announce the Dynamic Ventilator Reserve, a public-private online initiative to track and help distribute available ventilators and associated supplies to areas of the country with high COVID-19 infection…
A Centers for Disease Control and Prevention assessment affirms the ability of the two authorized mRNA COVID-19 vaccines to prevent hospitalization in fully vaccinated adults ages 65 and older.